Literature DB >> 6983582

A methodologic framework for developing and selecting endpoints in clinical trials.

P Tugwell, C Bombardier.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6983582

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  17 in total

1.  How do you know?

Authors:  J T Rosenbaum; A Deodhar; E B Suhler; J R Smith
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  On the classification of population health measurements.

Authors:  Ian McDowell; Robert A Spasoff; Betsy Kristjansson
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

Review 3.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

4.  [Clinical studies on multimodal pain therapy : Standardized measurement of therapy outcomes with a core outcome set].

Authors:  S Deckert; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

5.  Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Authors:  D M van der Heijde; M A van't Hof; P L van Riel; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ).

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

7.  Development of a measure of physical function for patients with bone and soft tissue sarcoma.

Authors:  A M Davis; J G Wright; J I Williams; C Bombardier; A Griffin; R S Bell
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

8.  The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA.

Authors:  T R Zijlstra; H J Bernelot Moens; M A S Bukhari
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

Review 9.  [Measuring disease activity for rheumatoid arthritis].

Authors:  D Aletaha; T Stamm; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 10.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.